Investors brace for Xp earnings as estimates cool in Brazil By Investing.com

XP is expected to report Q1 EPS of 2.57 reais on revenue of 4.88 billion reais, both up 12.2% year over year, though revenue is forecast to decline 1.4% sequentially from Q4. Analyst sentiment remains constructive with 10 of 13 analysts at buy and a $24.70 consensus target, implying 41% upside from the current $17.60 share price. However, estimates have drifted lower over the past 60 days, with EPS down 4% and revenue down 2%, highlighting some near-term caution despite continued growth.

Analysis

The key signal is not the quarter itself but the rate of deceleration in forward expectations after a long re-rating of the platform. When estimates stop falling week-to-week, the stock usually shifts from an "estimate-cut story" to a "prove-it story," which can reduce downside volatility if the print is merely in-line. The market is already pricing respectable execution, so the incremental upside now depends on management showing that client monetization and asset growth can outpace pricing pressure rather than just maintain share.

Competitive intensity is the bigger second-order issue. Traditional banks rolling out digital offerings can compress spreads faster than headline growth slows, meaning the real risk is margin mix, not client count. If affluent clients rotate toward alternative assets and advisory products, that helps revenue per client, but it also raises dependence on market-sensitive AUM and transaction activity, which makes the next 1-2 quarters more sensitive to Brazil rates and risk appetite than sell-side models imply.

The contrarian setup is that a "good enough" print may be enough to trigger a higher multiple expansion because expectations have already been softened by recent revisions. Conversely, if revenue merely matches consensus while commentary on cross-sell or client acquisition disappoints, the market could punish the name despite still-healthy growth because the implied 41% upside leaves little room for a lower-quality beat. This is a stock where guidance and cohort metrics matter more than EPS by itself over the next 3-6 months.

UBS’s raise matters less as a standalone call than as a sign that the buy-side debate is shifting from "is growth decelerating?" to "how durable is the platform moat?" If management shows any evidence of faster penetration into wealthier clients or alternatives, the multiple can re-rate quickly. If not, the stock likely trades as a high-quality but increasingly mature financial platform, where every basis point of margin pressure deserves a disproportionate haircut.

Key Decisions for Investors

• Hold a tactical long XP into earnings only via calls, not stock: buy 1-2 month out-of-the-money calls for upside convexity while capping downside if client-growth commentary disappoints.
• If already long XP, hedge into the print with a partial collar or short dated call spread; the risk/reward favors protecting gains because the stock needs a clean beat-and-raise to justify the current implied upside.
• Pair trade: long XP / short a Brazilian bank with an active digital push over the next 1-3 months; if XP proves it can defend margins, the cleaner asset-light model should outperform legacy balance-sheet businesses facing digital cannibalization.
• Do not add on a simple in-line EPS beat; wait for AUM, client acquisition, and alternative-asset mix to confirm that growth is coming from higher-quality monetization rather than market beta.
• If XP gaps up >5% on results without a raise in forward estimates, fade part of the move; at that point the market will likely be pricing perfection, and the next catalyst risk shifts to the next quarter's margin scrutiny.